• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of brmedjLink to Publisher's site
Br Med J. Jan 12, 1980; 280(6207): 66–68.
PMCID: PMC1600263

Molecular pathology of schizophrenia: more than one disease process?

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (758K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Randrup A, Munkvad I. Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia. 1967;11(4):300–310. [PubMed]
  • CARLSSON A, LINDQVIST M. EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. Acta Pharmacol Toxicol (Copenh) 1963;20:140–144. [PubMed]
  • Crow TJ, Gillbe C. Brain dopamine and behaviour. A critical analysis of the relationship between dopamine antagonism and therapeutic efficacy of neuroleptic drugs. J Psychiatr Res. 1974;11:163–172. [PubMed]
  • Miller RJ, Hiley CR. Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism. Nature. 1974 Apr 12;248(449):596–597. [PubMed]
  • Andén NE. Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs. J Pharm Pharmacol. 1972 Nov;24(11):905–906. [PubMed]
  • Crow TJ, Deakin JF, Longden A. The nucleus accumbens--possible site of antipsychotic action of neuroleptic drugs? Psychol Med. 1977 May;7(2):213–221. [PubMed]
  • Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 1976 Apr 30;192(4238):481–483. [PubMed]
  • Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 1976 Jun 24;261(5562):717–719. [PubMed]
  • Johnstone EC, Crow TJ, Frith CD, Carney MW, Price JS. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet. 1978 Apr 22;1(8069):848–851. [PubMed]
  • Bowers MB., Jr Central dopamine turnover in schizophrenic syndromes. Arch Gen Psychiatry. 1974 Jul;31(1):50–54. [PubMed]
  • Post RM, Fink E, Carpenter WT, Jr, Goodwin FK. Cerebrospinal fluid amine metabolites in acute schizophrenia. Arch Gen Psychiatry. 1975 Aug;32(8):1063–1069. [PubMed]
  • Owen F, Cross AJ, Crow TJ, Longden A, Poulter M, Riley GJ. Increased dopamine-receptor sensitivity in schizophrenia. Lancet. 1978 Jul 29;2(8083):223–226. [PubMed]
  • Lee T, Seeman P, Tourtellotte WW, Farley IJ, Hornykeiwicz O. Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains. Nature. 1978 Aug 31;274(5674):897–900. [PubMed]
  • Muller P, Seeman P. Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors. Life Sci. 1977 Dec 15;21(12):1751–1758. [PubMed]
  • Woolley DW, Shaw E. A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS. Proc Natl Acad Sci U S A. 1954 Apr;40(4):228–231. [PMC free article] [PubMed]
  • Jospeh MH, Baker HF, Crow TJ, Riley GJ, Risby D. Brain tryptophan metabolism in schizophrenia: a post mortem study of metabolites of the serotonin and kynurenine pathways in schizophrenic and control subjects. Psychopharmacology (Berl) 1979 Apr 25;62(3):279–285. [PubMed]
  • Randrup A, Munkvad I. Special antagonism of amphetamine-induced abnormal behaviour. Inhibition of stereotyped activity with increase of some normal activities. Psychopharmacologia. 1965 May 21;7(6):416–422. [PubMed]
  • Crow TJ, Johnstone EC, Deakin JF, Longden A. Dopamine and schizophrenia. Lancet. 1976 Sep 11;2(7985):563–566. [PubMed]
  • Murphy DL, Wyatt RJ. Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature. 1972 Jul 28;238(5361):225–226. [PubMed]
  • Crow TJ, Baker HF, Cross AJ, Joseph MH, Lofthouse R, Longden A, Owen F, Riley GJ, Glover V, Killpack WS. Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings. Br J Psychiatry. 1979 Mar;134:249–256. [PubMed]
  • Stein L, Wise CD. Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science. 1971 Mar 12;171(3975):1032–1036. [PubMed]
  • Cross AJ, Crow TJ, Killpack WS, Longden A, Owen F, Riley GJ. The activities of brain dopamine-beta-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls. Psychopharmacology (Berl) 1978 Oct 31;59(2):117–121. [PubMed]
  • Cotes PM, Crow TJ, Johnstone EC, Bartlett W, Bourne RC. Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication. Psychol Med. 1978 Nov;8(4):657–665. [PubMed]
  • Letemendia FJ, Harris AD. Chlorpromazine and the untreated chronic schizophrenic: a long-term trial. Br J Psychiatry. 1967 Sep;113(502):950–958. [PubMed]
  • Kornetsky C. Hyporesponsivity of chronic schizophrenic patients to dextroamphetamine. Arch Gen Psychiatry. 1976 Dec;33(12):1425–1428. [PubMed]
  • Crow TJ, Mitchell WS. Subjective age in chronic schizophrenia: evidence for a sub-group of patients with defective learning capacity? Br J Psychiatry. 1975 Apr;126:360–363. [PubMed]
  • Crow TJ, Stevens M. Age disorientation in chronic schizophrenia: the nature of the cognitive deficit. Br J Psychiatry. 1978 Aug;133:137–142. [PubMed]
  • HAUG JO. Pneumoencephalographic studies in mental disease. Acta Psychiatr Scand Suppl. 1962;38(165):1–104. [PubMed]
  • Johnstone EC, Crow TJ, Frith CD, Stevens M, Kreel L, Husband J. The dementia of dementia praecox. Acta Psychiatr Scand. 1978 Apr;57(4):305–324. [PubMed]
  • Weinberger DR, Torrey EF, Neophytides AN, Wyatt RJ. Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch Gen Psychiatry. 1979 Jul;36(7):735–739. [PubMed]
  • Crow TJ. Viral causes of psychiatric disease. Postgrad Med J. 1978 Nov;54(637):763–767. [PMC free article] [PubMed]
  • Tyrrell DA, Parry RP, Crow TJ, Johnstone E, Ferrier IN. Possible virus in schizophrenia and some neurological disorders. Lancet. 1979 Apr 21;1(8121):839–841. [PubMed]
  • Crow TJ, Ferrier IN, Johnstone EC, Macmillan JF, Owens DG, Parry RP, Tyrrell DA. Characteristics of patients with schizophrenia or neurological disorder and virus-like agent in cerebrospinal fluid. Lancet. 1979 Apr 21;1(8121):842–844. [PubMed]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...